Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

A new compound, BOI, can help hair grow by changing hair cycle phases and increasing certain cell contents.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Unable to summarize document.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Snakin-Z from jujube fruits may help treat Alzheimer's due to its enzyme inhibition and antioxidant properties.

The document's conclusion cannot be provided because the document is not readable or understandable.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

Meis1 is crucial for skin health and tumor development.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.